XHKG
2666
Market cap1.16bUSD
Oct 09, Last price
4.56HKD
1D
1.11%
1Q
-0.22%
Jan 2017
-28.86%
IPO
-34.01%
Name
Genertec Universal Medical Group Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Genertec Universal Medical Group Company Limited, founded in 1984 and based in Beijing, China, provides extensive financing and advisory services across the People's Republic of China, alongside operating a significant healthcare business. The company's operations are segmented into two primary divisions. The Finance and Advisory segment delivers a range of services including direct finance leasing, sale-and-leaseback arrangements, factoring, operating leases, and various advisory offerings. Meanwhile, its Hospital Group segment focuses on providing medical care, managing hospitals and healthcare facilities, and conducting import, export, and general trading of medical-related goods. Beyond these core areas, Genertec Universal Medical also engages in medical technology development, hospital digitalization, construction, and management services, as well as property management and medical consulting. The company serves a diverse clientele, encompassing patients, hospitals, medical equipment suppliers, and other public sector organizations. In July 2018, the company adopted its current name, having previously operated as Universal Medical Financial & Technical Advisory Services Company Limited.
Key people
Shisu Chen
Executive Chairman of the Board · since 2024
Wenbing Wang
Chief Executive Officer, Executive Director · since 2021
Lin Wang
Executive Director · since 2023
Wai Kam Ng
Company Secretary · since 2019
Tong Chaoyin
Non-Executive Director · since 2021
Youjie Huang
Non-Executive Director · since 2025
Chunhai Lin
Non-Executive Director · since 2025
Wanming Ma
Non-Executive Director · since 2025
Non-Executive Independent Director · since 2022
Non-Executive Independent Director · since 2015
Non-Executive Independent Director · since 2015
Zhiming Xu
Non-Executive Independent Director · since 2022
Legal address
RM 702, Fairmont House
8 Cotton Tree Drive
Central
Hong Kong 999077
HK
8 Cotton Tree Drive
Central
Hong Kong 999077
HK
Headquarters
9th&10th floor, West Wing of Sichuan Building
No.1, Fuwai Street
Xicheng District
Beijing 065001
CN
No.1, Fuwai Street
Xicheng District
Beijing 065001
CN
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||